BACKGROUND/AIMS: Indication of hepatectomy for liver metastases from @entity356 (LMGC) is still controversial despite many papers favoring surgery. The aim of this study is to claim that we should accept hepatectomy as first choice treatment for LMGC. It is important to have a consensus on this matter for surgeons to treat LMGC properly. METHODOLOGY: Fifty three @entity1 undergoing hepatectomy for LMGC from 1990 through 2010 were retrospectively analysed for survival and prognostic factors. Analyses were made on size, multiplicity, @entity7158 and positive surgical margin as liver @entity3 factors. Serosal invasion, node @entity3 , histological differentiation and UICC stage were analysed as primary site factors. Multivariate analysis was performed for those positive for univariate analysis. RESULTS: Cumulative 5 year survival rate was 27%. Multiplicity, positive margin and node @entity3 (N > 2) yielded significant difference on univariate analysis. On multivariate analysis multiplicity and node @entity3 (N > 2) were significant. CONCLUSION: Hepatectomy for LMGC is potentially curative and should be regarded as first choice. Solitary and N < 3 are good prognostic factors.

Hepatectomy As A First Choice Treatment For Liver Metastasis From XXXX : A Single Center Experience.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity7158 :: ('MESH:D009378', 'Disease') :: ['synchronicity'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis']
@entity356 :: (MESH:D013274,Disease) :: ['Gastric Cancer']
